| Course | NUR 602 Advanced Pharmacology Across the Life Span |
|---|---|
| Module | Module 1 |
| Paper type | Discussion post on evidence applicability across the life span |
| Length | About 420 words, 3 pages |
| Format | APA 7 student paper |
| School | Southern New Hampshire University |
| Program | MSN |
| Updated | September 2026 |
Free sample paper for NUR 602 Module 1
Module One Discussion
Reading the Exclusion List First
When I look up the evidence for a drug, I now read the exclusion criteria before the results. The reason is a patient like this composite: an 84-year-old woman in assisted living with mild dementia, two falls this year and a blood pressure of 158/76 mm Hg on amlodipine 5 mg. The question is whether to add a second drug and aim lower.
Two trials seem to answer it. The Hypertension in the Very Elderly Trial enrolled adults aged 80 and older and found that treating toward 150/80 mm Hg reduced total mortality and heart failure compared with placebo (Beckett et al., 2008). A subgroup of adults aged 75 and older in the SPRINT trial found fewer cardiovascular events with a systolic target below 120 mm Hg than with a target below 140 (Williamson et al., 2016). Read quickly, both support lowering her pressure, and one suggests lowering it a lot.
Read carefully, neither enrolled her. HYVET excluded people with dementia and those needing nursing care, and its participants were, on the whole, healthier than typical 80-year-olds. The SPRINT analysis excluded nursing home residents, people with dementia and people with diabetes or prior stroke. This is not unusual. A review of heart failure trials found that many excluded older adults outright through upper age limits and that many more excluded them indirectly through conditions common in later life (Cherubini et al., 2011).
So recommendations for her rest on extrapolation, and the balance may be different. Her remaining life expectancy is shorter, which reduces the time for benefit, while her risk of harm from lower pressure is higher: orthostatic drops, falls and fractures, and possibly worse cognition if cerebral perfusion falls. For her, I would check lying and standing pressure, review her fall history with her and her daughter and suggest keeping her current regimen with a systolic goal near 150 unless orthostatic symptoms argue for less. I would also say plainly in her chart that the evidence does not include people like her.
Extrapolation is not wrong; it is often all we have. But it should be named, because it changes how firmly I recommend something and how much weight I give to her own priorities. When I asked a similar patient's family what mattered most, the answer was staying on her feet and knowing her grandchildren, not a lower number.
Question for classmates: how often do you check who was excluded from a trial before applying its result, and how would you explain that uncertainty to a family?
References
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., Belhani, A., Forette, F., Rajkumar, C., Thijs, L., Banya, W., & Bulpitt, C. J. (2008). Treatment of hypertension in patients 80 years of age or older. New England Journal of Medicine, 358(18), 1887-1898. https://doi.org/10.1056/NEJMoa0801369
Cherubini, A., Oristrell, J., Pla, X., Ruggiero, C., Ferretti, R., Diestre, G., Clarfield, A. M., Crome, P., Hertogh, C., Lesauskaite, V., Prada, G.-I., Szczerbinska, K., Topinkova, E., Sinclair-Cohen, J., Edbrooke, D., & Mills, G. H. (2011). The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Archives of Internal Medicine, 171(6), 550-556. https://doi.org/10.1001/archinternmed.2011.31
Williamson, J. D., Supiano, M. A., Applegate, W. B., Berlowitz, D. R., Campbell, R. C., Chertow, G. M., Fine, L. J., Haley, W. E., Hawfield, A. T., Ix, J. H., Kitzman, D. W., Kostis, J. B., Krousel-Wood, M. A., Launer, L. J., Oparil, S., Rodriguez, C. J., Roumie, C. L., Shorr, R. I., Sink, K. M., . . . Pajewski, N. M. (2016). Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: A randomized clinical trial. JAMA, 315(24), 2673-2682. https://doi.org/10.1001/jama.2016.7050
What the NUR 602 Module 1 instructions ask for
The opening NUR 602 discussion usually asks you to explore a principle of prescribing across the life span, often how evidence, pharmacokinetics or patient factors shape a drug decision, and then respond to classmates. Prompts may name a population, such as older adults, children or pregnant patients, and ask how prescribing should change. First posts are often 300 to 500 words and cite two or more scholarly sources in APA 7, and replies should add a new point or source. Ground your post in a specific patient and a specific decision, since abstract statements about age-related change earn less credit than a worked example that shows how the principle changes what you would actually prescribe. Cite the trial itself where you can.
How this NUR 602 Module 1 discussion example is built
The sample uses a composite 84-year-old woman with mild dementia, two falls and a blood pressure of 158/76 mm Hg to ask whether to intensify treatment. It summarizes what two landmark trials in older adults found, then reads their exclusion criteria and shows that neither enrolled people with dementia or needing care. A review of heart failure trials shows the problem is widespread. The post explains how shorter life expectancy and higher fall risk shift the balance of benefit and harm, proposes a plan with a goal near 150 mm Hg and ends with a question about how classmates handle and explain this kind of uncertainty to families. Three real sources support the post.
Where the NUR 602 Module 1 rubric puts the points
Discussion posts in NUR 602 are generally scored on accurate pharmacology, application to a patient across the life span, integration of evidence, APA 7 citation and meaningful peer engagement. Graders reward posts that evaluate evidence critically, for example by checking whether a trial population matches the patient, rather than simply citing results. Explaining how benefit and harm shift with age or comorbidity shows graduate-level reasoning. Replies score well when they add a contrasting population, a new source or a different decision, while replies that only agree earn little. Timely posting and professional tone are usually part of the rubric too, so plan around the posting deadlines. Naming extrapolation openly also shows maturity.
NUR 602 Module 1 help: the mistakes that cost points
First-week pharmacology posts often lose points by quoting a guideline without asking whether it fits the patient, by describing age-related changes in general terms or by leaving out a concrete decision. Choose a real prescribing question, summarize the key evidence, check who the trials excluded, explain how the balance of benefit and harm changes for your patient and state what you would do and how you would document the uncertainty. Close by asking peers something they can answer from their own practice. If your prompt focuses on a child, a pregnancy or another decision, share the prompt and rubric so a first post can be written with the same evidence-first approach for your population. A half-finished draft is welcome for review as well.
Get NUR 602 Module 1 written to your instructions
Send the discussion prompt and the patient or population it names. A first post that tests the evidence against the patient and reaches a clear prescribing decision is ready in 24 to 48 hours, and the first one is free. The paper above is an original model document written by our desk, not a submitted student paper and not an official Southern New Hampshire University document.
More NUR 602 papers and related MSN samples
- NUR 520 Module 5 Statistical Inference Paper: Confidence Intervals Around County Estimates
- NUR 555 Module 5 Comparison Paper: Iron Deficiency Anemia and Anemia of Inflammation Compared
- NUR 601 Module 1 Discussion: The Baroreflex and Neurogenic Orthostatic Hypotension
- NUR 560 Module 2 Focused Assessment: Chest Pain in a 58-Year-Old With a Ranked Differential
NUR 602 Module 1 questions, answered
Where can I find a free NUR 602 Module 1 Discussion sample?
The post on this page is free to read: prescribing for a composite 84-year-old with dementia and falls when blood pressure trials excluded people like her, with APA 7 citations.
Why do exclusion criteria matter when applying trial results?
They show who the results were tested in. If a patient would have been excluded, applying the result is extrapolation and the balance of benefit and harm may differ.
What did the HYVET trial show?
In adults aged 80 and older, treating toward 150/80 mm Hg reduced total mortality and heart failure compared with placebo. It excluded people with dementia and those needing nursing care.
Are older adults often excluded from drug trials?
Yes. A review of heart failure trials found many excluded older patients by age limits or indirectly through common conditions of later life.
How should uncertainty about evidence be handled in practice?
Weigh likely benefit against harm for the individual, share the uncertainty with the patient and family and document that the evidence does not directly include them.